Nanoparticles in Angiogenesis and Cancer [Hardcover]

This book highlights recent developments of organic and inorganic nanomedicine that play a major role in anti-angiogenic cancer therapy.  In addition, the authors present examples of nanomedicine based anti-angiogenic agents and their applications in cancer therapy.  Angiogenesis is a pathophysiological phenomenon that modulates cell proliferation and cell migration and plays important roles in cancer.  Anti-angiogenic nanotherapies have gained immense attention in recent times as alternative cost-effective therapies that opened a new dimension in cancer theranostics.  Further the challenges of the anti-angiogenic nanotherapies and possible future perspective are detailed.Chapter 1 - Introduction.- Chapter 2 - Current Anti-angiogenic Therapies and their Limitations.- Chapter 3 - Nanomedicine.- Chapter 4 - Organic Nanoparticles in Anti-angiogenic Cancer Therapy.- Chapter 5 - Inorganic Nanoparticles in Anti-angiogenic Cancer Therapy.- Chapter 6 - Potential Challenges in Anti-angiogenic Nanotherapies.- Chapter 7 - Conclusion.Sudip Mukherjee, Ph.D., is a Research Scientist at Rice University. His research interests include the development of advanced biomaterials for cell therapy, drug/gene delivery in diabetes, cancer theranostics, angiogenesis, and immunomodulatory applications. Dr. Mukherjee serves as an Associate Editor for various journals including BMC Cancer and Frontiers in Chemistry and is also a reviewer for several international journals, such as Chem Comm, Journal of Materials Chemistry A, Journal of Materials Chemistry B, ACS Nano, Biomaterials, RSC Advances, IOP Nanotechnology, and Biofabrication.